Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

261 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prophylactic low-level light therapy for the treatment of hypertrophic scars and keloids: a case series.
Barolet D, Boucher A. Barolet D, et al. Among authors: boucher a. Lasers Surg Med. 2010 Aug;42(6):597-601. doi: 10.1002/lsm.20952. Lasers Surg Med. 2010. PMID: 20662038
The aim of this case series was to investigate the effectiveness of near infrared (NIR) light emitting diode (LED) treatment as a prophylactic method to alter the wound healing process in order to avoid or attenuate the formation of hypertrophic scars or keloids. ...Effica …
The aim of this case series was to investigate the effectiveness of near infrared (NIR) light emitting diode (LED) treatment as a pro …
No-needle jet intradermal aminolevulinic Acid photodynamic therapy for recurrent nodular Basal cell carcinoma of the nose: a case report.
Barolet D, Boucher A. Barolet D, et al. Among authors: boucher a. J Skin Cancer. 2011;2011:790509. doi: 10.1155/2011/790509. Epub 2010 Oct 18. J Skin Cancer. 2011. PMID: 21188233 Free PMC article.
To enhance topical delivery of drugs intradermally, a needleless jet injection (NLJI), which employs a high-speed jet to puncture the skin without the side effects of needles, was used in one patient with recurrent BCC of the nose. ...
To enhance topical delivery of drugs intradermally, a needleless jet injection (NLJI), which employs a high-speed jet to punct …
Radiant near infrared light emitting Diode exposure as skin preparation to enhance photodynamic therapy inflammatory type acne treatment outcome.
Barolet D, Boucher A. Barolet D, et al. Among authors: boucher a. Lasers Surg Med. 2010 Feb;42(2):171-8. doi: 10.1002/lsm.20886. Lasers Surg Med. 2010. PMID: 20166163 Clinical Trial.
STUDY DESIGN/MATERIALS AND METHODS: Ten patients exhibiting inflammatory acne with a lesion count of > or =10 were assigned to a split face or split back group. ...Pre-PDT radiant IR LED exposure appears to be a promising method to enhance PDT efficacy for …
STUDY DESIGN/MATERIALS AND METHODS: Ten patients exhibiting inflammatory acne with a lesion count of > or =10 were assigned to …
LED photoprevention: reduced MED response following multiple LED exposures.
Barolet D, Boucher A. Barolet D, et al. Among authors: boucher a. Lasers Surg Med. 2008 Feb;40(2):106-12. doi: 10.1002/lsm.20615. Lasers Surg Med. 2008. PMID: 18306161 Clinical Trial.
Moreover, there was evidence of a dose-related pattern in results. Finally, a sun protection factor SPF-15-like effect and a reduction in post-inflammatory hyperpigmentation were observed on the LED pre-treated side. ...The induction of cellular resistance to …
Moreover, there was evidence of a dose-related pattern in results. Finally, a sun protection factor SPF-15-like effect and …
Regulation of skin collagen metabolism in vitro using a pulsed 660 nm LED light source: clinical correlation with a single-blinded study.
Barolet D, Roberge CJ, Auger FA, Boucher A, Germain L. Barolet D, et al. Among authors: boucher a. J Invest Dermatol. 2009 Dec;129(12):2751-9. doi: 10.1038/jid.2009.186. Epub 2009 Jul 9. J Invest Dermatol. 2009. PMID: 19587693 Clinical Trial.
Furthermore, profilometry quantification revealed that more than 90% of individuals showed a reduction in rhytid depth and surface roughness, and, via a blinded clinical assessment, that 87% experienced a reduction in the Fitzpatrick wrinkling severity score …
Furthermore, profilometry quantification revealed that more than 90% of individuals showed a reduction in rhytid depth and surface ro …
Conversion from twice-daily to once-daily extended-release tacrolimus in renal transplant recipients: 2-year results and review of the literature.
Tran D, Vallée M, Collette S, Senécal L, Lafrance JP, Dandavino R, Boucher A. Tran D, et al. Among authors: boucher a. Exp Clin Transplant. 2014 Aug;12(4):323-7. doi: 10.6002/ect.2013.0165. Epub 2014 May 19. Exp Clin Transplant. 2014. PMID: 24844288 Review.
To validate the safety and efficacy of extended-release formula tacrolimus, we conducted a prospective observational study. MATERIALS AND METHODS: At our institution, between January 2009 and January 2010, the switch from tacrolimus to extended-release formula tacrolimus w …
To validate the safety and efficacy of extended-release formula tacrolimus, we conducted a prospective observational study. MATERIALS …
Retrospective Study Looking at Cinacalcet in the Management of Hyperparathyroidism after Kidney Transplantation.
Mawad H, Bouchard H, Tran D, Ouimet D, Lafrance JP, Bell RZ, Bezzaoucha S, Boucher A, Collette S, Pichette V, Senécal L, Vallée M. Mawad H, et al. Among authors: boucher a. J Transplant. 2017;2017:8720283. doi: 10.1155/2017/8720283. Epub 2017 Mar 13. J Transplant. 2017. PMID: 28386475 Free PMC article.
Twenty-seven patients were included with a mean follow-up of 2.9 ± 2.4 years. Twenty-one were already taking cinacalcet at the time of transplantation. ...There was no statistically significant association between baseline factors and cinacalcet status a year later. …
Twenty-seven patients were included with a mean follow-up of 2.9 ± 2.4 years. Twenty-one were already taking cinacalcet at the time o …
The incidence, management, and evolution of rapamycin-related side effects in kidney transplant recipients.
Verhave J, Boucher A, Dandavino R, Collette S, Senécal L, Hebert MJ, Girardin C, Cardinal H. Verhave J, et al. Among authors: boucher a. Clin Transplant. 2014 May;28(5):616-22. doi: 10.1111/ctr.12361. Epub 2014 Apr 19. Clin Transplant. 2014. PMID: 24654608
Conversion from a calcineurin-inhibitor-based immunosuppression to a rapamycin-based immunosuppression may preserve kidney graft function. ...We performed a retrospective cohort study in patients transplanted before December 31, 2008 and who received rapamyci …
Conversion from a calcineurin-inhibitor-based immunosuppression to a rapamycin-based immunosuppression may preserve kidney gra …
Difficulty of patient selection in a combined heart-kidney transplant: a case report.
Goupil R, Bonnardeaux A, Boucher A, Collette S, Ouimet D, Sénécal L, Tran D, Vallée M. Goupil R, et al. Among authors: boucher a. Exp Clin Transplant. 2014 Jun;12(3):273-6. doi: 10.6002/ect.2013.0038. Epub 2014 Feb 25. Exp Clin Transplant. 2014. PMID: 24568727
We report the case of a man with ischemic cardiomyopathy and chronic kidney disease who was wait-listed for heart-kidney transplant after acute decompensated heart failure and renal failure requiring hemodialysis. ...This issue is primordial to improve selection of patient …
We report the case of a man with ischemic cardiomyopathy and chronic kidney disease who was wait-listed for heart-kidney transplant a …
Factors associated with progression of interstitial fibrosis in renal transplant patients receiving tacrolimus and mycophenolate mofetil.
Rush DN, Cockfield SM, Nickerson PW, Arlen DJ, Boucher A, Busque S, Girardin CE, Knoll GA, Lachance JG, Landsberg DN, Shapiro RJ, Shoker A, Yilmaz S. Rush DN, et al. Among authors: boucher a. Transplantation. 2009 Oct 15;88(7):897-903. doi: 10.1097/TP.0b013e3181b723f4. Transplantation. 2009. PMID: 19935461 Clinical Trial.
CONCLUSIONS: A regimen of tacrolimus, mycophenolate mofetil, and prednisone results in excellent renal function at 24 months posttransplant but with a progressive increase in IF/TA. A potential inhibitory effect of angiotensin-II-converting enzyme inhibitor/a …
CONCLUSIONS: A regimen of tacrolimus, mycophenolate mofetil, and prednisone results in excellent renal function at 24 months posttran …
261 results
Jump to page
Feedback